Repression of PTEN expression by PTEN siRNAs or SF1670 (PTEN inhibitor) rescued the tumor-inhibiting effect of DOK7 overexpression, suggesting that DOK7 inhibits proliferation, migration, and invasion of breast cancer cells though the PI3K/PTEN/AKT pathway. Here, AKT1 is linked to breast cancer.